Major Depressive Disorder

Resource Center

News
News
Resources
Depression Care360
FDA Alerts
Interactive
Polls Quizzes

Featured

Conference Coverage
Mark ZImmerman, MD
Conference Coverage
Major Depressive Disorder: Emerging Treatments
11/28/2022
11/28/2022
Conference Coverage
Person speaking to a therapist as the therapist takes notes.
Conference Coverage
Diagnosis, Management Strategies for Treatment-Resistant Depression
11/18/2022
11/18/2022
Conference Coverage
medical diagnosis
Conference Coverage
Pop Quiz: Treatment Options for Patients With Major Depressive Disorder
10/31/2022
10/31/2022

Interactive Features

Conference Coverage
medical diagnosis
Conference Coverage
Pop Quiz: Treatment Options for Patients With Major Depressive Disorder
10/31/2022
10/31/2022
Conference Coverage
A woman with her head in her hands.
Conference Coverage
Pop Quiz: Major Depressive Disorder in the United States
10/25/2022
10/25/2022
Major Depressive Disorder
Charles DeBattista, DMH, MD
Major Depressive Disorder
Poll: Patient Engagement, Adherence in Patients With Depression
09/27/2022
09/27/2022
Depression
marijuana
Depression
Pediatric Pearls: Cannabis and Depression in Adolescents
07/28/2022
After a check-up, the mother of a 16-year-old boy asks about the risks associated with cannabis use in adolescents. The mother commonly uses cannabis, and is curious about what effects it could have on her...
07/28/2022
adherence
adherence
Pop Quiz: Factors for Reduced Treatment Response Rates
01/11/2022
Recent evidence suggests several factors may contribute to reduced response rates to serotonin-selective reuptake inhibitors in patients with major depressive disorder. Do you know which factors?
01/11/2022

Clinical Insights

Conference Coverage
Mark ZImmerman, MD
Conference Coverage
Major Depressive Disorder: Emerging Treatments
11/28/2022
11/28/2022
Conference Coverage
Saundra Jain, MA, PsyD, LPC, and Manish K. Jha, MBBS
Conference Coverage
Measurement-Based Care in Major Depressive Disorder
09/29/2022
09/29/2022
Treatment
Treatment
Jennifer Dwyer, MD, PhD, on Intravenous Ketamine in Adolescents with Treatment Resistant Depression
03/16/2022
Dr Jennifer Dwyer discusses the results from her randomized, double-blind, placebo-controlled crossover trial study that found a reduction in depression scores at 24 hours post treatments with ketamine...
03/16/2022